from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2358/smtB

LFCtreatmentdescriptionclass of inhibitor

1.069

Amikacinug/mL Amikacintranslation

0.398

Cap5-10ug/mL Capreomycintranslation

0.277

Rox10-50 ug/mL Roxithromycintranslation

0.420

SM2-5 ug/mL Streptomycintranslation

2.392

Tet5-10 ug/mL Tetracyclinetranslation

-0.048

Rif0.2-5ug/mL Rifampicintranscription

-0.524

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.273

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.714

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.319

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.318

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.562

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.569

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.452

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.062

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.091

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.134

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.450

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.553

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.317

KCN5-20 ug/mL Potassium cyaniderespiration

-0.301

NaN30.2-2 mM Sodium aziderespiration

-0.217

Nigericin50 uM Nigericinrespiration

0.286

TRC10-150 ug/mL Triclosanrespiration

0.669

TRZ10-25 ug/mL Thioridazinerespiration

0.136

Valinomycin0.5-10 uM Valinomycinrespiration

0.612

ZnSO42 mM ZnSO4respiration

0.966

menadione6-10 ug/mL Menadionerespiration

0.717

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.615

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.128

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.592

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.158

NRP_1Non-replicating persistence stage 1dosRassociated

-0.374

Amp0.2mg/mL AmpicillincellWall

-0.535

Cephalexin20-100 ug/mL CephalexincellWall

-0.971

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.669

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.048

EMB10-20 ug/mL EthambutolcellWall

0.015

Eta12-40 ug/mL EthionamidecellWall

0.124

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.556

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.310

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.194

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.408

BZA0.12 mg/mL BenzamidearomaticAmides

-0.107

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.494

H2O24 mM hydrogen peroxideDNAdamaging

-0.421

Levo10 ug/mL LevofloxacinDNAdamaging

-0.192

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.159

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.001

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.389

UVUV-irradiationDNAdamaging

0.637

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.917

Antimycin12.5-50 ug/mL Antimycin A?

-1.106

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.738

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.881

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.219

PA8240.2-2 ug/mL PA-824?

1.780

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.349

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.679

Verapamil50 uM Verapamil?

-0.693

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.114

methoxatin10-20 ug/mL Methoxatin?